Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...
Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a ...
The partners are preparing for commercialization of the lung cancer drug limertinib as they await an approval decision from China’s National Drug Administration.